Discover

News & Info

Quote List Quote List

ASCLETIS-B(01672.HK)

Event Tracking

Mar31

ASCLETIS-B released FY2025 9 Months Earnings on March 31, 2026 (BJT), with actual revenue of HKD 1.688 M and EPS of HKD -0.2502

15:00

ASCLETIS-B released FY2025 Q3 earnings on March 31, 2026 (BJT) with actual revenue of HKD 517.61 K and EPS of HKD -0.1513

15:00

GALIRA BIOPHARMA-B Reports Increased Revenue and Widening Loss in 2025

14:36

ASCLETIS-B released FY2025 Q4 earnings on March 31 After-Market (BJT), actual revenue HKD 526.55 K, actual EPS HKD -0.1539

11:00

ASCLETIS-B released FY2025 Annual Earnings on March 31 After-Market (BJT), actual revenue HKD 2.217 M (forecast HKD 856.54 K), actual EPS HKD -0.4045 (forecast HKD -0.385)

11:00

Mar24

ASCLETIS-B to Release FY2025 Earnings on March 31 After-Market (BJT), Forecast Revenue HKD 876.49 K, EPS HKD -0.3939

03:26

Schedules & Filings

Schedules

Filings

Mar31

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 526.55 K, Net Income -151.2 M, EPS -0.1539

Genscript Biotech Corporation (1672.HK) 2025 Annual Performance Conference Call

Genscript Biotech Corporation (1672.HK) 2025 Annual Performance Conference Call

Aug15

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 591.59 K, Net Income -48.13 M, EPS -0.05

Gere Pharmaceutical (1672.HK) 2025 Mid-Year Performance Conference Call

Gere Pharmaceutical (1672.HK) 2025 Mid-Year Performance Conference Call

Mar26

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 682.46 K, Net Income -90.76 M, EPS -0.0919

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More